Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only-mode. At the end of the prepared ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew OSA Clinical Advisory Board Announced; Appoints Dr. Al ...

Many of us pay attention to the foods we're putting in our bodies – asking ourselves whether they're nutritious and healthy ...

More than 800,000 U.S. children have what's called "high threshold" peanut allergy, meaning they can tolerate about h ...

Ideaya is financially strong, with $1.2 billion in cash reserves, sufficient to fund operations into at least 2028. Click ...

A study at Mount Sinai has shown that children with a high tolerance for peanuts can significantly increase their resistance ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Discover how gut motility affects your health, learn about gut transit time, and find out how to test your gut speed with ...

Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the activated form ...

Many of us pay attention to the foods we’re putting in our bodies — asking ourselves whether they’re nutritious and healthy for us. But have you ever stopped to ask yourself how fast this food is ...